Oralabs Cold Sore Treatment
Product Images NDC 63645-162

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Oralabs Cold Sore Treatment (NDC 63645-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oralabs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Front And Back Of Card For Oralabs Cst (Image 01)

OraLabs Cold Sore Treatment packaging label features a blue background with white and red accents. The label highlights FDA approval and the active ingredient benzocaine 5%, indicating its use for cold sore and fever blister treatment. The labeler is OraLabs, and the net weight is 2g (0.07oz). The label also shows a caduceus symbol and the word NEW in red. Directions and warnings are detailed on the reverse side, but the front prominently displays the product name and branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.